ArticleJournal of experimental & clinical cancer research : CR2026
Soulangianolide A targets FAM120A to disrupt SREBP1-driven lipid metabolic reprogramming and suppress clear cell renal cell carcinoma.
Wei Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.